8
Views
14
CrossRef citations to date
0
Altmetric
Anticancer Chemotherapy

Vitamin C Modulation of Cisplatin-Induced Cytogenotoxicity in Bone Marrow, Spermatogonia and its Transmission in the Male Germline of Swiss Mice

Pages 182-187 | Published online: 18 Jul 2013

References

  • Chabner BA, Allegra CJ, Curt GA, Calabresi P. Antineoplastic agents. In: Hardman JG, et al. (eds.). Goodman and Gilman's The pharmaceutical Basis of thera-peutics. New York, McGraw Hill, 1996; 1233-1285.
  • Weiss RB, Christian MC. New cisplatin drugs in devel-opment. Drugs. 1993; 46: 362–377.
  • Jackson MA, Stack HF, Waters MD. Genetic activity profiles of anticancer drugs. Mutat Res 1996; 355: 171–208.
  • Sanderson BJS, Ferguson LR, Denny WA. Mutagenic and carcinogenic properties of platinum-based anticancer drugs. Mutat Res 1996; 355: 59–70.
  • Choudhury RC, Jagdale MB, Misra S. Cytogenetic toxic-ity of cisplatin in bone marrow cells of Swiss mice. J Chemother 2000; 12 (2): 173–182.
  • Choudhury RC, Jagdale MB, Misra S. Potential trans-mission of the cytogenetic effects of cisplatin in the male germline cells of Swiss mice. J Chemother 2000; 12 (4): 352–359.
  • Noda N, Wakasugi H. Cancer and oxidative stress. JMAJ. 2001; 44 (12): 535–539.
  • Weijl NI, Hopman GD, Wipkink-Bakker A, et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998; 9: 1331–1337.
  • Cozzi R, Ricordy R, Aglitti T, Gatta V, Perticone P, De Salvia R. Ascorbic acid and I3-carotene as modulators of oxidative damage. Carcinogenesis 1997; 18 (1): 223–228.
  • Choudhury RC, Jagdale MB. Vitamin E protection from/ potentiation of the cytogenetic toxicity of cisplatin inSwiss mice. J Chemother 2002; 14 (4): 397–405.
  • Seifried HE, McDonald SS, Anderson DE, Greenwald P, Milner JA. The antioxidant conundrum in cancer. Cancer Res 2003; 63: 4295–4298.
  • Wenzel U, Nickel A, Kunz S, Daniel H. Ascorbic acid suppresses drug-induced apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Carcinogenesis 2004; 25 (5): 703–712.
  • Prasad KN. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity. Int Cancer Ther 2004; 3 (4): 310–322.
  • Chatterjee IB, Mukhopadhyay CK, Ghosh MK. Vitamin C: A potential saviour against free radical-induced oxidative damage. Curr Sci 1995; 69 (9): 747–751.
  • Shamberger RJ. Genetic toxicology of ascorbic acid. Mutat Res 1984; 133: 135–159.
  • Khan PK, Sinha SP. Impact of higher dose of vitamin C in modulating pesticide genotoxicity. Teratogen Carcinogen Mutagen 1994; 14: 175–181.
  • Halliwell B. Vitamin C: the key to health or a slow act-ing carcinogen? Redox Report 1994; 1: 5–9.
  • Aly FAE, Donya SM. In vivo antimutagenic effect of vit-amin C and E against rifampicin-induced chromosome aberra-tions in mouse bone-marrow cells. Mutat Res 2002; 518: 1–7.
  • Blasiak J, Gloc E, Drzewoski J, Wozniak K, Zadrozny M, Skorski T, Pertynski T. Free radical scavengers can differ-entially modulate the genotoxicity of amsacrine in normal and cancer cells. Mutat Res 2003; 535: 25–34.
  • Vissers MCM, Lee WG, Hampton MB. Regulation of apoptosis by vitamin C. J Biol Chem 2001; 276 (50): 46835–46840.
  • Sane AT, Cantin AM, Paquette B, Wagner JR. Ascorbate modulation of H202 and camptothecin-induced cell death in jurkat cells. Cancer Chemother Pharmacol 2004; 54: 315–321.
  • Carr A, Frei B. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J 1999; 13: 1007-1024.
  • Halliwell B. Vitamin C: antioxidant or prooxidant in vivo? Free Rad Res 1996; 25: 439–454.
  • Podomore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998; 392: 559.
  • Halliwell B. The antioxidant paradox. Lancet 2000; 355: 1179–1180.
  • Ames BN. DNA damage from micronutrient deficien-cies is likely to be a major cause of cancer. Mutat Res 2001; 475: 7–20.
  • Fraga CG, Motchnik PA, Wyrobek AJ, Rempel DM, Ames BN. Smoking and low antioxidant levels increase oxida-tive damage to sperm DNA. Mutat Res 1996; 351: 199–203.
  • Carr AC, Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am J Clin Nutr 1999; 69: 1086–1107.
  • Rehman A, Collis CS, Yang M, et al. The effects of iron and vitamin C co-supplementation on oxidative damage to DNA in healthy volunteers. Biochem Biophys Res Commun 1998; 246: 293–298.
  • Yu BP. Cellular defenses against damage from reactive oxygen species. Physiolog Rev 1994; 73: 139–162.
  • Sakagami H, Satoh K, Hakeda Y, Kumegawa M. Apoptosis inducing activity of vitamin C and vitamin K. Cell Mol Biol 2000; 46: 129–143.
  • Song JH, Shin SH, Wang W, Ross GM. Involvement of oxidative stress in ascorbate-induced pro-aptotic death of PC 12 cells. Exp Neurol 2001; 169: 425–437.
  • Kang JS, Cho DH, Kim YI, Hahm E, Yang YH, Kim D, Hur D, Park H, Bang S, Hwang YI, Lee WJ. L-ascorbic acid (vitamin C) induces the apoptosis of B16 murine melanomal cells via caspase-8-independent pathway. Cancer Immunol Immunother 2003; 52: 693–698.
  • El-Nahas SM, Mattar FE, Mohamed AA. Radioprotective effect of vitamin C and E. Mutat Res 1993; 301: 143–147.
  • Bose S, Sinha SP. Modulation of ochratoxin-produced genotoxicity in mice by vitamin C. Food Chem Toxicol 1994; 32 (6): 533–537.
  • Yoshikawa Y, Suzuki M, Chen N, Zinchenko AA, Murata S, Kanbe T, Nakai T, Oana H, Yoshikawa K. Ascorbic acid induces a marked conformational change in long duplex DNA. Eur J Biochem 2003; 270: 3101–3106.
  • Khan PK, Sinha SP. Antimutagenic efficacy of higher doses of vitamin C. Mutat Res 1993; 298: 157–161.
  • Kang SA, Gang YJ, Park M. In vivo dual effects of vit-amin C on paraquat-induced lung damage: dependence on released metals from the damaged tissue. Free Rad Res 1998; 28: 93–107.
  • Park CH, Amare M, Savin MA, Hoogstraten B. Growth suppression of human leukaemic cells in vitro by L-ascorbic acid. Cancer Res 1980; 40: 1062–1065.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.